Launch of OncoSTART consortium supporting oncology entrepreneurs
Twelve expert partners join forces and combine networks to drive entrepreneurial innovation against cancer
Created at the initiative of MATWIN, the French accelerator dedicated to oncology innovation, the OncoSTART consortium brings together 12 key national players in research and innovation in the fight against cancer, pooling their specific expertise, know-how and networks. This new group aims to drive the creation of high added-value start-ups in the oncology sector and support the development of a network with a more visible international presence to better cater to patients’ needs.
The OncoSTART steering committee currently has 12 members:
● Cancer research clusters (cancéropôles) : CLARA (Canceropole Lyon Auvergne-Rhône-Alpes), Sud (Provence Alpes Côte d’Azur), Grand-Ouest (Brittany, Centre, Pays de la Loire) and Nord-Ouest (Normandy, Hauts de France)
● The Carnot Institutes specifically targeting cancer: Curie Cancer, CALYM for lymphomas and OPALE for leukemia and related diseases
● The Cancer Campus biocluster
● The Gustave Roussy Comprehensive Cancer Center
● The MATWIN innovation accelerator (the consortium’s coordinator)
● LS LEAD training center (Life Science Leadership School)
● The Unicancer hospital network
The Covid health crisis demonstrated that many biotechnology companies spun off from academic research have the ability to offer disruptive innovations (vaccines, tests, etc.). Oncology is a good example of this trend, with recent developments by early-stage businesses in the areas of immunotherapy, CAR-T cells, e-health and artificial intelligence. Given that start-up creation is a key marker of the ecosystem’s capacity for innovation, the OncoSTART consortium has chosen to promote and support these ventures to accelerate and strengthen the development of innovations for the benefit of patients.
To know more 👉 read the press release.